This article is free to access.
This article is inter alia a brief, first-stop guide to possible adverse events (AEs) associated with tafenoquine (TQ) intake. Safety and efficacy findings for TQ in Plasmodium vivax malaria prophylaxis and radical cure are summarized and some of the latest TQ-related studies (published in 2020 and 2021) are highlighted. In addition, little-known biological and other matters concerning malaria parasites and 8-aminoquinoline (8-AQ) drug action are discussed and some correct terminology pertinent to malaria is explained.
Markus, M. B. (2021). Safety and efficacy of tafenoquine for plasmodium vivax malaria prophylaxis and radical cure: Overview and perspectives. Therapeutics and Clinical Risk Management, 17, 989–999. https://doi.org/10.2147/TCRM.S269336
Mendeley helps you to discover research relevant for your work.